Indaptus Therapeutics Secures $12M in Deeply Discounted Private Placement
INDP has more than doubled off its 52-week low of $0.92 on light trading volume (0.1× avg).
Summary
Indaptus Therapeutics raised $12 million through a private placement at a steep discount, providing a temporary cash lifeline but significantly diluting existing shareholders.
Key Events · Financing and Capital Events · INDP
-
$12 Million Private Placement Completed
The company issued 20,000,000 shares of common stock at a purchase price of $0.60 per share, generating approximately $12 million in gross proceeds from non-U.S. accredited investors.
-
Significant Discount and Dilution
The offering price of $0.60 per share represents an 83% discount to the current stock price of $3.55. This issuance increases the company's outstanding shares by 17.66%.
-
Critical Cash Infusion for Distressed Company
This capital raise provides a short-term financial lifeline for the company, which recently reported a critically low cash balance of $1.5 million and a high quarterly burn rate of $7.0 million, along with a going concern warning.
-
Registration Rights Granted
Purchasers were granted certain registration rights, requiring the company to file a registration statement for the resale of these shares within 90 days of the June 17, 2026 closing date.
Analysis · INDP · Life Sciences
Indaptus Therapeutics has completed a private placement, raising $12 million by issuing 20 million shares at $0.60 per share. While this provides a critical cash infusion for a company facing a dire financial state and a going concern warning, the offering price represents a significant discount to the current market price. This highly dilutive transaction, increasing outstanding shares by nearly 18%, underscores the company's urgent need for capital and the challenging terms it must accept to secure funding.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, INDP was trading at $3.55 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $402M. The 52-week trading range was $0.92 to $14.84. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.